Developmental neurotoxicity testing: A path forward

Congenital Anomalies

Volumn 52, Issue 3, 2012, Pages 140-146

  Crofton, Kevin M ^a   Mundy, William R ^a   Shafer, Timothy J ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Chemical screening; Developmental neurotoxicity; Integrated evaluation strategy

Indexed keywords

LEAD; METHYLMERCURY; POLYCHLORINATED BIPHENYL DERIVATIVE;

BRAIN DEVELOPMENT; CELL ASSAY; CELL FREE SYSTEM; COMPUTER MODEL; DEVELOPMENTAL NEUROTOXICITY; IN VITRO STUDY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; ZEBRA FISH;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; HUMANS; MODELS, BIOLOGICAL; NEUROTOXICITY SYNDROMES; TOXICITY TESTS;

ANIMALIA; DANIO RERIO;

EID: 84865560583     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/j.1741-4520.2012.00377.x     Document Type: Review

References (66)

1. Ali S, Champagne DL, Richardson MK. 2012. Behavioral profiling of zebrafish embryos exposed to a panel of 60 water-soluble compounds. Behav Brain Res 228:272-283.
2. Andersen ME, Krewski D. 2009. Toxicity testing in the 21st century: bringing the vision to life. Toxicol Sci 107:324-330.
3. Aoyama H. 2012. Developmental neurotoxicity testing: scientific approaches towards the next-generation to protect the developmental nervous system of children. An overview of the DNT Symposium in 2011. Congenit Anom (Kyoto) 52:119-121.
4. Bal-Price A, Coecke S, Costa L etal. 2012. Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. ALTEX 29:202-215.
5. Breier JM, Radio NM, Mundy WR, Shafer TJ. 2008. Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol Sci 105:119-133.
6. Busch W, Duis K, Fenske M etal. 2011. The zebrafish embryo model in toxicology and teratology, September 2-3, 2010, Karlsruhe, Germany. Reprod Toxicol 31:585-588.
7. Chiu LL, Cunningham LL, Raible DW, Rubel EW, Ou HC. 2008. Using the zebrafish lateral line to screen for ototoxicity. J Assoc Res Otolaryngol 9:178-190.
8. Coecke S, Goldberg AM, Allen S etal. 2007. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ Health Perspect 115:924-931.
9. Collins FS, Gray GM, Bucher JR. 2008. Toxicology. Transforming environmental health protection. Science 319:906-907.
10. Crofton KM, Zoeller RT. 2005. Mode of action: neurotoxicity induced by thyroid hormone disruption during development - hearing loss resulting from exposure to PHAHs. Crit Rev Toxicol 35:757-769.
11. Crofton KM, Mundy WR, Lein PJ etal. 2011. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX 28:9-15.
12. D'Amico LJ, Li CQ, Seng WL, McGrath P. 2008. Developmental neurotoxicity assessment in zebrafish: a survey of 200 environmental toxicants (Abstract). Society of Toxicology.
13. Dobbing J. 1968. Vulnerable periods in developing brain. In: Davison AN, Dobbing J, editors. Applied Neurochemistry. Oxford: Blackwell. p 287-316.
14. EDF. 1997. Toxic ignorance: the continuing absence of basic health testing for top-selling chemicals in the United States. Washington, DC: Environmental Defense Fund.
15. El Yazal J, Rao SN, Mehl A, Slikker W Jr. 2001. Prediction of organophosphorus acetylcholinesterase inhibition using three-dimensional quantitative structure-activity relationship (3D-QSAR) methods. Toxicol Sci 63:223-232.
16. Fritsche E, Gassmann K, Schreiber T. 2011. Neurospheres as a model for developmental neurotoxicity testing. Methods Mol Biol 758:99-114.
17. Gross GW, Harsch A, Rhoades BK, Gopel W. 1997. Odor, drug and toxin analysis with neuronal networks in vitro: extracellular array recording of network responses. Biosens Bioelectron 12:373-393.
18. Harrill JA, Mundy WR. 2011. Quantitative assessment of neurite outgrowth in PC12 cells. Methods Mol Biol 758:331-348.
19. Harrill JA, Robinette BL, Mundy WR. 2011. Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro. Toxicol In Vitro 25:368-387.
20. Hartung T. 2010. Evidence-based toxicology - the toolbox of validation for the 21st century? ALTEX 27:253-263.
21. Hewitt M, Ellison CM, Enoch SJ, Madden JC, Cronin MT. 2010. Integrating (Q)SAR models, expert systems and read-across approaches for the prediction of developmental toxicity. Reprod Toxicol 30:147-160.
22. Hill EJ, Woehrling EK, Prince M, Coleman MD. 2008. Differentiating human NT2/D1 neurospheres as a versatile in vitro 3D model system for developmental neurotoxicity testing. Toxicology 249:243-250.
23. Hogberg HT, Kinsner-Ovaskainen A, Coecke S, Hartung T, Bal-Price AK. 2010. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol Sci 113:95-115.
24. Hogberg HT, Sobanski T, Novellino A, Whelan M, Weiss DG, Bal-Price AK. 2011. Application of micro-electrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acid-induced effects in primary cultures of rat cortical neurons. Neurotoxicology 32:158-168.
25. Huang H, Huang C, Wang L etal. 2010. Toxicity, uptake kinetics and behavior assessment in zebrafish embryos following exposure to perfluorooctanesulphonicacid (PFOS). Aquat Toxicol 98:139-147.
26. Judson R, Richard A, Dix DJ etal. 2009. The toxicity data landscape for environmental chemicals. Environ Health Perspect 117:685-695.
27. Kavlock R, Dix D. 2010. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk. J Toxicol Environ Health B Crit Rev 13:197-217.
28. Kavlock RJ, Austin CP, Tice RR. 2009. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal 29:485-487. discussion 492-7.
29. Kuegler PB, Zimmer B, Waldmann T etal. 2010. Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX 27:17-42.
30. Kuwagata M. 2012. Current problems of in vivo study and new in vivo approach focusing on each step of the developing CNS. Congenit Anom (Kyoto) 52:129-139.
31. Landrigan PJ. 2010. What causes autism? Exploring the environmental contribution. Curr Opin Pediatr 22:219-225.
32. Lein P, Locke P, Goldberg A. 2007. Meeting report: alternatives for developmental neurotoxicity testing. Environ Health Perspect 115:764-768.
33. MacPhail RC, Brooks J, Hunter DL, Padnos B, Irons TD, Padilla S. 2009. Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology 30:52-58.
34. Makris SL, Raffaele K, Allen S etal. 2009. A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect 117:17-25.
35. Malygin VV, Sokolov VB, Richardson RJ, Makhaeva GF. 2003. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates. J Toxicol Environ Health A 66:611-625.
36. Martin MT, Knudsen TB, Reif DM etal. 2011. Predictive model of rat reproductive toxicity from ToxCast high throughput screening. Biol Reprod 85:327-339.
37. McDonald ME, Paul JF. 2010. Timing of increased autistic disorder cumulative incidence. Environ Sci Technol 44:2112-2118.
38. Mileson BE, Ferenc SA. 2001. Methods to identify and characterize developmental neurotoxicity for human health risk assessment: overview. Environ Health Perspect 109(Suppl 1):77-78.
39. Miller MD, Crofton KM, Rice DC, Zoeller RT. 2009. Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect 117:1033-1041.
40. Moors M, Rockel TD, Abel J etal. 2009. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ Health Perspect 117:1131-1138.
41. Mundy WR, Radio NM, Freudenrich TM. 2010. Neuronal models for evaluation of proliferation in vitro using high content screening. Toxicology 270:121-130.
42. Nishimura Y, Takeuchi S, Misawa T, Kon T, Tanaka T. 2011. Development of zebrafish-based assays for the assessment of DNT caused by exposure to chemicals at low doses. Abstract presented at the Third International Conference on Alternatives for Developmental Neurotoxicity Testing, Varese Italy, May 2011.
43. Novellino A, Scelfo B, Palosaari T etal. 2011. Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals. Front Neuroeng 4(4):1-14.
44. NRC. 1984. National research council. Toxicity testing: strategies to determine needs and priorities. Washington, DC: The National Academies Press. ISBN 0-309-03433-7.
45. NRC. 2007. Toxicity testing in the 21st century: a vision and a strategy. Washington, DC: National Academy Press. ISBN 0-309-13412-9.
46. OECD. 2007. OECD guidelines for the testing of chemicals/section 4: health effects. Test No. 426: developmental neurotoxicity study. http://www.oecd.org/dataoecd/20/52/37622194.pdf [accessed May 21, 2012].
47. Radio NM, Mundy WR. 2008. Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 29:361-376.
48. Radio NM, Breier JM, Shafer TJ, Mundy WR. 2008. Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening. Toxicol Sci 105:106-118.
49. Rauh VA, Garfinkel R, Perera FP etal. 2006. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3years of life among inner-city children. Pediatrics 118:e1845-e1859.
50. Reif DM, Martin MT, Tan SW etal. 2010. Endocrine profiling and prioritization of environmental chemicals using ToxCast data. Environ Health Perspect 118:1714-1720.
51. Rice D, Barone S Jr. 2000. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(Suppl. 3):511-533.
52. Robinette BL, Harrill JA, Mundy WR, Shafer TJ. 2011. In vitro assessment of developmental neurotoxicity: use of microelectrode arrays to measure functional changes in neuronal network ontogeny. Front Neuroeng 4:1-9.
53. Sakai Y, Yoshida S, Yoshiura Y etal. 2010. Effect of microwell chip structure on cell microsphere production of various animal cells. J Biosci Bioeng 110:223-229.
54. Schuurmann G, Ebert RU, Kuhne R. 2011. Quantitative read-across for predicting the acute fish toxicity of organic compounds. Environ Sci Technol 45:4616-4622.
55. Sipes NS, Martin MT, Reif DM etal. 2011a. Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data. Toxicol Sci 124:109-127.
56. Sipes NS, Padilla S, Knudsen TB. 2011b. Zebrafish: as an integrative model for twenty-first century toxicity testing. Birth Defects Res C Embryo Today 93:256-267.
57. Slikker W Jr, Xu ZA, Levin ED, Slotkin TA. 2005. Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction - developmental neurotoxicity of nicotine. Crit Rev Toxicol 35:703-711.
58. Teraoka H, Dong W, Hiraga T. 2003. Zebrafish as a novel experimental model for developmental toxicology. Congenit Anom (Kyoto) 43:123-132.
59. Tikhonova OV, Skvortsov VS, Raevskii OA. 2011. Molecular modeling of acetylcholinesterase interaction with irreversible and reversible organophosphorous inhibitors. Biomed Khim 57:61-76.
60. Ton C, Lin Y, Willett C. 2006. Zebrafish as a model for developmental neurotoxicity testing. Birth Defects Res A Clin Mol Teratol 76:553-567.
61. Tsuji R, Crofton KM. 2012. The developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation. Congenit Anom (Kyoto) 52:122-128.
62. US EPA. 1998a. Health effects guidelines OPPTS 870.6300 developmental neurotoxicity study. Office of Prevention Pesticides and Toxic Substances.
63. US EPA. 1998b. Chemical hazard data availability study. What do we really know about the safety of high production volume chemicals? US Environmental Protection Agency http://www.epa.gov/HPV/pubs/general/hazchem.htm.
64. US EPA. 2011. Framework for an EPA chemical safety for sustainability research program. Office of Research and Development, US Environmental Protection Agency, Washington, DC (June 1, 2001).
65. Volz DC, Belanger S, Embry M etal. 2011. Adverse outcome pathways during early fish development: a conceptual framework for identification of chemical screening and prioritization strategies. Toxicol Sci 123:349-358.
66. Zoeller RT, Crofton KM. 2005. Mode of action: developmental thyroid hormone insufficiency - neurological abnormalities resulting from exposure to propylthiouracil. Crit Rev Toxicol 35:771-781.